KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
15.18
+1.18 (8.43%)
At close: Sep 10, 2025, 4:00 PM
15.27
+0.09 (0.59%)
After-hours: Sep 10, 2025, 4:00 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $106.58 million as of September 10, 2025. Its market cap has increased by 286.16% in one year.
Market Cap
106.58M
Enterprise Value
96.28M
1-Year Change
286.16%
Ranking
Category
Stock Price
$15.18
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $106.58M, a decrease of -75.24%. That is a compound annual growth rate of -15.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 98.30M | 207.19% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |